GE HealthCare Technologies (GEHC) Total Current Liabilities (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Total Current Liabilities came in at $8.3 billion in Q2 2026, down 14.83% on a YoY basis from $9.7 billion in Q2 2025, and down 2.66% quarter-over-quarter from $8.5 billion in Q1 2026.
Analysis
GE HealthCare Technologies (GEHC) Total Current Liabilities (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has reported Total Current Liabilities for 5 consecutive years, with $8.3 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities fell 14.83% year-over-year to $8.3 billion; the trailing twelve-month figure through Jun 2026 stood at $8.3 billion (down 14.83% YoY), and the FY2025 full-year result was $9.1 billion, down 4.69% from the prior year.
- Total Current Liabilities slipped to $8.3 billion in Q2 2026 per GEHC's latest filing, from $8.5 billion in the prior quarter.
- Across five years, Total Current Liabilities topped out at $10.1 billion in Q3 2025 and bottomed at $7.2 billion in Q4 2022.
- Historically, Total Current Liabilities has averaged $8.7 billion across 5 years, with a median of $8.7 billion in 2024.
- The sharpest annual moves came in 2023 and 2026: Total Current Liabilities increased 24.89% in 2023, then fell 14.83% in 2026.
- Over 5 years, Total Current Liabilities stood at $7.2 billion in 2022, then rose by 24.89% to $9.0 billion in 2023, then increased by 6.37% to $9.6 billion in 2024, then dropped by 4.69% to $9.1 billion in 2025, then declined by 8.82% to $8.3 billion in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $8.3 billion, $8.5 billion, and $9.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 8.30 Bn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 335.68 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | 44.09 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 158.20 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | 58.60 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | 993.40 Mn |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | 17.20 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | 87,836.00 |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 187.40 Mn |
| 10 | Prenetics Global | 357.49 Mn | 298.35 Mn | 30.20 Mn | 36.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.30 Bn |
| Mar 31, 2026 | 8.53 Bn |
| Dec 31, 2025 | 9.11 Bn |
| Sep 30, 2025 | 10.07 Bn |
| Jun 30, 2025 | 9.75 Bn |
| Mar 31, 2025 | 9.97 Bn |
| Dec 31, 2024 | 9.55 Bn |
| Sep 30, 2024 | 8.67 Bn |
| Jun 30, 2024 | 8.32 Bn |
| Mar 31, 2024 | 8.86 Bn |
| Dec 31, 2023 | 8.98 Bn |
| Sep 30, 2023 | 7.57 Bn |
| Jun 30, 2023 | 7.58 Bn |
| Mar 31, 2023 | 8.24 Bn |
| Dec 31, 2022 | 7.19 Bn |